Tuan Vu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Interstitial Lung Disease

Myasthenia Gravis

Top Venues

Journal of neurology

The New England journal of medicine

Neurology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
Tuan Vu, Andreas Meisel, Renato Mantegazza, Djillali Annane, Masahisa Katsuno, Rasha Aguzzi, Ahmed Enayetallah, Kathleen N Beasley, Nishi Rampal, James F Howard
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. Neurology and therapy (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie, Zoltan Griger, Sergey Moiseev, Chester Oddis, Elena Schiopu, Jiri Vencovský, Irene Beckmann, Elisabeth Clodi, Olga Bugrova, Katalin Dankó, Floranne Ernste, Namita A Goyal, Marvin Heuer, Marie Hudson, Yessar M Hussain, Chafic Karam, Nina Magnolo, Ronald Nelson, Nataliia Pozur, Liudmyla Prystupa, Miklós Sárdy, Guillermo Valenzuela, Anneke J van der Kooi, Tuan Vu, Margitta Worm, Todd Levine, null null
Trial of Intravenous Immune Globulin in Dermatomyositis. The New England journal of medicine 387 (14) (2022)
Tuan Vu, Natalie Anthony, Raul Alsina, Brittany Harvey, Allison Schleutker, Jerrica Farias, Samuel Dang, Niraja Suresh, Clifton Gooch
Impact of subcutaneous immunoglobulin on quality of life in patients with chronic inflammatory demyelinating polyneuropathy previously treated with intravenous immunoglobulin. Muscle & nerve 64 (3) (2021)